Duncan McHale, M.B.B.S.
2018
In 2018, Duncan McHale, M.B.B.S. earned a total compensation of $2.3M as Chief Medical Officer at Evelo Biosciences, a 171% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,280 |
|---|---|
| Option Awards | $1,737,874 |
| Salary | $371,242 |
| Other | $20,105 |
| Total | $2,290,501 |
MBBS received $1.7M in option awards, accounting for 76% of the total pay in 2018.
MBBS also received $161.3K in non-equity incentive plan, $371.2K in salary and $20.1K in other compensation.
Rankings
In 2018, Duncan McHale, M.B.B.S.'s compensation ranked 5,042nd out of 14,244 executives tracked by ExecPay. In other words, MBBS earned more than 64.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,042 out of 14,244 | 65th |
Division Manufacturing | 1,895 out of 5,759 | 67th |
Major group Chemicals And Allied Products | 694 out of 2,122 | 67th |
Industry group Drugs | 580 out of 1,811 | 68th |
Industry Pharmaceutical Preparations | 446 out of 1,385 | 68th |
Source: SEC filing on April 25, 2019.
MBBS' colleagues
We found two more compensation records of executives who worked with Duncan McHale, M.B.B.S. at Evelo Biosciences in 2018.